Sponsor or institution
Clinical trials and research at AvenCell Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by AvenCell Therapeutics, Inc. that are recruiting, at sites in 3 countries (most in Germany (2), Netherlands (1), United States (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Off-the-shelf CAR-T Allo-QuadCAR01-T targeting CD19 and CD20 for relapsed or refractory B‑cell cancers
This study will test an off-the-shelf donor CAR-T that targets CD19 and CD20 to try to treat adults with relapsed or refractory B‑cell lymphomas or leukemias.
-
Treatment for patients with specific types of blood cancer using engineered T-cells
This study is testing a new treatment using specially modified T-cells to see if it can help patients with a type of blood cancer called acute myeloid leukemia that hasn't responded to other therapies.
Quick answers
How many clinical trials run by AvenCell Therapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Germany (2 trials), Netherlands (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.